Cargando…

Lacosamide and sodium channel‐blocking antiepileptic drug cross‐titration against levetiracetam background therapy

OBJECTIVE: To assess prospectively the effectiveness of lacosamide (LCM) added to levetiracetam (LEV) after down‐titration of a concomitant sodium channel blocker (SCB) among patients with focal epilepsy not adequately controlled on LEV and SCB. METHODS: In this open‐label trial, LCM was initiated a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baulac, M., Byrnes, W., Williams, P., Borghs, S., Webster, E., De Backer, M., Dedeken, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347878/ https://www.ncbi.nlm.nih.gov/pubmed/27714769 http://dx.doi.org/10.1111/ane.12691

Ejemplares similares

Lacosamide/levetiracetam/valproate: Lack of efficacy: case report
Publicado: (2022)

Lacosamide and Levetiracetam Have No Effect on Sharp-Wave Ripple Rate
por: Kudlacek, Jan, et al.
Publicado: (2017)

The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide
por: van Opijnen, Mark P., et al.
Publicado: (2021)

Effects of levetiracetam and lacosamide on therapeutic efficacy and neural function in patients with epilepsy
por: Liu, Airong, et al.
Publicado: (2020)

Lacosamide monotherapy in clinical practice: A retrospective chart review
por: Villanueva, V., et al.
Publicado: (2018)

Analyses of seizure responses supportive of a novel trial design to assess efficacy of antiepileptic drugs in infants and young children with epilepsy: Post hoc analyses of pediatric levetiracetam and lacosamide trials
por: Johnson, Martin E., et al.
Publicado: (2021)

Levetiracetam Liver Injury: A Benign Antiepileptic Agent?
por: Hegazy, Yassmin, et al.
Publicado: (2023)

Additional Antiepileptic Mechanisms of Levetiracetam in Lithium-Pilocarpine Treated Rats
por: Al-Shorbagy, Muhammad Y., et al.
Publicado: (2013)

Acute Liver Failure Associated with Levetiracetam and Lacosamide Combination Treatment for Unspecified Epileptic Disorder
por: Gutiérrez-Grobe, Ylse, et al.
Publicado: (2013)

COT-31 Risk Factors for the Development of Skin Rash with Levetiracetam and Lacosamide in Patients with Glioma
por: Onodera, Mikoto, et al.
Publicado: (2021)

Equipotency of lacosamide to levetiracetam in new onset focal epilepsy: A randomized controlled trial
por: Jaiswal, Binaya Kumar, et al.
Publicado: (2023)

Understanding the challenge of comparative effectiveness research in focal epilepsy: A review of network meta‐analyses and real‐world evidence on antiepileptic drugs
por: Thieffry, Solène, et al.
Publicado: (2020)

The sodium channel-blocking antiepileptic drug phenytoin inhibits breast tumour growth and metastasis
por: Nelson, Michaela, et al.
Publicado: (2015)

Interactions among Lacosamide and Second-Generation Antiepileptic Drugs in the Tonic-Clonic Seizure Model in Mice
por: Załuska-Ogryzek, Katarzyna, et al.
Publicado: (2021)

The antiepileptic drug levetiracetam improves auditory gating in DBA/2 mice
por: Smucny, Jason, et al.
Publicado: (2015)

Lacosamide Associated Complete Heart Block in Elderly
por: Bhana, Indu Ghanshyam, et al.
Publicado: (2019)

Levetiracetam Versus Levetiracetam Plus Sodium Channel Blockers for Postoperative Epileptic Seizure Prevention in Brain Tumor Patients
por: Watanabe, Noriyuki, et al.
Publicado: (2022)

Antiepileptic Drug of Levetiracetam Decreases Centrotemporal Spike-Associated Activation in Rolandic Epilepsy
por: Zhang, Qirui, et al.
Publicado: (2018)

Health care cost associated with the use of enzyme-inducing and non-enzyme–active antiepileptic drugs in the UK: a long-term retrospective matched cohort study
por: Borghs, Simon, et al.
Publicado: (2017)

Development of lacosamide for the treatment of partial-onset seizures
por: Doty, Pamela, et al.
Publicado: (2013)

Efficacy and tolerability of adjunctive lacosamide in pediatric patients with focal seizures
por: Farkas, Viktor, et al.
Publicado: (2019)

Antiepileptic Drug Titration and Related Health Care Resource Use and Costs
por: Fishman, Jesse, et al.
Publicado: (2018)

Comparing healthcare cost associated with the use of enzyme-inducing and non-enzyme active antiepileptic drugs in elderly patients with epilepsy in the UK: a long-term retrospective, matched cohort study
por: Borghs, Simon, et al.
Publicado: (2020)

Changes in drug load during lacosamide combination therapy: A noninterventional, observational study in German and Austrian clinical practice
por: Reinhardt, Fritjof, et al.
Publicado: (2019)

Mechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs: Focus on Topiramate, Levetiracetam, and Perampanel
por: Hansen, Cerine C., et al.
Publicado: (2018)

Safety and tolerability of lacosamide monotherapy in the elderly: A subgroup analysis from lacosamide trials in diabetic neuropathic pain
por: Bainbridge, Jacquelyn, et al.
Publicado: (2017)

Genetic Background of Epilepsy and Antiepileptic Treatments
por: Borowicz-Reutt, Kinga, et al.
Publicado: (2023)

First‐line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid
por: van der Meer, Pim B., et al.
Publicado: (2021)

Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to Adenocarcinoma
por: Sulsenti, Roberta, et al.
Publicado: (2021)

Physiologically‐based pharmacokinetic modeling of oxcarbazepine and levetiracetam during adjunctive antiepileptic therapy in children and adolescents
por: Sinha, Jaydeep, et al.
Publicado: (2021)

Left Bundle Branch Block: A Reversible Pernicious Effect of Lacosamide
por: Majmundar, Monil M, et al.
Publicado: (2020)

Chimeric Agents Derived from the Functionalized Amino Acid, Lacosamide, and the α-Aminoamide, Safinamide: Evaluation of Their Inhibitory Actions on Voltage-Gated Sodium Channels, and Antiseizure and Antinociception Activities and Comparison with Lacosamide and Safinamide
por: Park, Ki Duk, et al.
Publicado: (2014)

Novel antiepileptic drug lacosamide exerts neuroprotective effects by decreasing glial activation in the hippocampus of a gerbil model of ischemic stroke
por: AHN, JI YUN, et al.
Publicado: (2015)

Neuroprotective effects of novel antiepileptic drug lacosamide via decreasing glial activation in the hippocampus of a gerbil model of ischemic stroke
por: Cho, JH, et al.
Publicado: (2015)

Effects of lacosamide and carbamazepine on lipids in a randomized trial
por: Mintzer, Scott, et al.
Publicado: (2020)

Inverse Association between Sodium Channel-Blocking Antiepileptic Drug Use and Cancer: Data Mining of Spontaneous Reporting and Claims Databases
por: Takada, Mitsutaka, et al.
Publicado: (2016)

Lacosamide-associated second-degree atrioventricular block in a healthy, young athlete
por: Stamm, Brian, et al.
Publicado: (2020)

Levetiracetam/sodium valproate: Lack of efficacy: case report
Publicado: (2022)

A thermosensitive mutation alters the effects of lacosamide on slow inactivation in neuronal voltage-gated sodium channels, Na(V)1.2
por: Abdelsayed, Mena, et al.
Publicado: (2013)

Lacosamide on background eeg activity in brain tumor‐related epilepsy patients: A case series study
por: Maschio, Marta, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kfotcqfgbq4ee833g1fm0f9l8k